Thierry VandenDriessche

ORCID: 0000-0003-4230-745X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Virus-based gene therapy research
  • CRISPR and Genetic Engineering
  • CAR-T cell therapy research
  • RNA Interference and Gene Delivery
  • Hemophilia Treatment and Research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Pluripotent Stem Cells Research
  • Muscle Physiology and Disorders
  • Viral Infections and Immunology Research
  • Biomedical Ethics and Regulation
  • Platelet Disorders and Treatments
  • Tissue Engineering and Regenerative Medicine
  • Animal Genetics and Reproduction
  • Viral gastroenteritis research and epidemiology
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Biomedical and Engineering Education
  • Biochemical and Molecular Research
  • Liver physiology and pathology
  • Animal Virus Infections Studies
  • Mesenchymal stem cell research
  • Genetic Neurodegenerative Diseases
  • Immunotherapy and Immune Responses
  • Electrospun Nanofibers in Biomedical Applications
  • Mitochondrial Function and Pathology

KU Leuven
2014-2024

Vrije Universiteit Brussel
1990-2024

Bio-Medical Science (South Korea)
2004-2019

Université Libre de Bruxelles
2016

VIB-KU Leuven Center for Cancer Biology
2016

University College London
2015

Kyushu University
2014

Salk Institute for Biological Studies
2014

Baylor College of Medicine
2014

Institute for Recent History of Serbia
2014

Abstract Adeno-associated virus (AAV) forms the basis for several commercial gene therapy products and countless transfer vectors derived from natural or synthetic viral isolates that are under intense preclinical evaluation. Here, we report a versatile pipeline enables direct side-by-side comparison of pre-selected AAV capsids in high-throughput same animal, by combining DNA/RNA barcoding with multiplexed next-generation sequencing. For validation, create three independent libraries...

10.1038/s41467-020-19230-w article EN cc-by Nature Communications 2020-10-28

Transposon-based gene vectors have become indispensable tools in vertebrate genetics for applications ranging from insertional mutagenesis and transgenesis model species to therapy humans. The transposon toolkit is expanding, but a careful, side-by-side characterization of the diverse systems has been lacking. Here we compared Sleeping Beauty (SB), piggyBac (PB), Tol2 transposons with respect overall activity, overproduction inhibition (OPI), target site selection, transgene copy number as...

10.1038/mt.2010.47 article EN cc-by-nc-nd Molecular Therapy 2010-04-07

Abstract Lentiviral vectors are attractive tools for liver-directed gene therapy because of their capacity stable expression and the lack preexisting immunity in most human subjects. However, use integrating may raise some concerns about potential risk insertional mutagenesis. Here we investigated liver transfer by integrase-defective lentiviral (IDLVs) containing an inactivating mutation integrase (D64V). Hepatocyte-targeted using IDLVs resulted sustained robust induction immune tolerance...

10.1002/hep.24230 article EN Hepatology 2011-02-18

CRISPR/Cas9 is an attractive platform to potentially correct dominant genetic diseases by gene editing with unprecedented precision. In the current proof-of-principle study, we explored use of for gene-editing in myotonic dystrophy type-1 (DM1), autosomal-dominant muscle disorder, excising CTG-repeat expansion 3′-untranslated-region (UTR) human protein kinase (DMPK) DM1 patient-specific induced pluripotent stem cells (DM1-iPSC), DM1-iPSC-derived myogenic and myoblasts. To eliminate...

10.1093/nar/gky548 article EN cc-by-nc Nucleic Acids Research 2018-06-05

Bioengineering of viral vectors for therapeutic gene delivery is a pivotal strategy to reduce doses, facilitate manufacturing, and improve efficacy patient safety. Here, we engineered myotropic adeno-associated (AAV) via semirational, combinatorial approach that merges AAV capsid peptide library screens. We first identified shuffled AAVs with increased specificity in the murine skeletal muscle, diaphragm, heart, concurrent liver detargeting. Next, boosted muscle by displaying on surface. In...

10.1126/sciadv.abn4704 article EN cc-by-nc Science Advances 2022-09-21

Hemophilia A is caused by a deficiency in coagulation factor VIII (FVIII) and predisposes to spontaneous bleeding that can be life-threatening or lead chronic disabilities. It well suited for gene therapy because moderate increase plasma FVIII concentration has therapeutic effects. Improved retroviral vectors expressing high levels of human were pseudotyped with the vesicular stomatitis virus G glycoprotein, concentrated high-titers (10 9 –10 10 colony-forming units/ml), injected...

10.1073/pnas.96.18.10379 article EN Proceedings of the National Academy of Sciences 1999-08-31

Abstract Antiparasite responses are associated with the recruitment of monocytes that differentiate to macrophages and dendritic cells at site infection. Although classically activated monocytic assumed be major source TNF NO during Trypanosoma brucei infection, their cellular origin remains unclear. In this study, we show bone marrow-derived accumulate TNF/inducible synthase-producing (TIP-DCs) in spleen, liver, lymph nodes T. brucei-infected mice. TIP-DCs have been shown play a beneficial...

10.4049/jimmunol.182.2.1107 article EN The Journal of Immunology 2009-01-15

Colon cancer accounts for more than 10% of all deaths annually. Our genetic evidence from Drosophila and previous in vitro studies mammalian Atonal homolog 1 (Atoh1, also called Math1 or Hath1) suggest an anti-oncogenic function the group proneural basic helix-loop-helix transcription factors. We asked whether mouse Atoh1 human ATOH1 act as tumor suppressor genes vivo. Genetic knockouts molecular analyses cell lines support a ATOH1. antagonizes formation growth by regulating proliferation...

10.1371/journal.pbio.1000039 article EN cc-by PLoS Biology 2009-02-20

Background— The progressive shift from a young to an aged heart is characterized by alterations in the cardiac matrix. present study investigated whether matricellular protein thrombospondin-2 (TSP-2) may affect dimensions and function with physiological aging of heart. Methods Results— TSP-2 knockout (KO) wild-type mice were followed up age 60 weeks. Survival rate, function, morphology did not differ at KO compared mice. However, >55% died between 24 weeks age, whereas <10% died. In...

10.1161/circulationaha.109.863266 article EN Circulation 2009-10-06
Coming Soon ...